Related Experiment Video
Updated: May 5, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Higher adiposity in infancy associated with recurrent wheeze in a prospective cohort of children
Elsie M Taveras1, Sheryl L Rifas-Shiman, Carlos A Camargo
1Obesity Prevention Program, Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA. Elsie_Taveras@hphc.org
Insights
Infants with higher weight-for-length (WFL) z scores at 6 months had increased odds of recurrent wheezing by age 3. Early interventions for infant adiposity may reduce asthma symptoms in children.
Area of Science:
- Pediatric Health
- Respiratory Medicine
- Epidemiology
Background:
- Limited prospective data exist on the link between early childhood adiposity and asthma symptoms.
- Childhood obesity is a growing public health concern with potential long-term health implications.
Purpose of the Study:
- To investigate the association between weight-for-length (WFL) z scores at 6 months of age and the incidence of wheezing by age 3 years.
- To explore the relationship between early adiposity and subsequent respiratory symptoms in infants.
Main Methods:
- A prospective cohort study of 932 children was conducted.
- Recurrent wheezing was defined as parental report of wheezing between 2-3 years plus wheezing in years 1 or 2.
- Multiple logistic regression analysis was used to assess the association of 6-month WFL z scores with wheezing outcomes.
Main Results:
- A higher WFL z score at 6 months was associated with increased odds of recurrent wheezing (OR, 1.46) and any wheezing (OR, 1.23) by age 3.
- Each 1-unit increase in 6-month WFL z score correlated with a 46% greater odds of recurrent wheezing.
- A weaker association was observed between 6-month WFL z score and current asthma.
Conclusions:
- Higher infant adiposity, indicated by WFL z scores at 6 months, is linked to a greater risk of recurrent wheezing by age 3.
- Findings suggest that early interventions targeting infant adiposity may be beneficial in reducing the risk of asthma-related symptoms.
- Further research is needed to understand the long-term implications for allergic asthma and persistent wheeze.
Background:
Few prospective data link early childhood adiposity with asthma-related symptoms.
Objective:
We sought to examine the associations of weight-for-length (WFL) at age 6 months with incidence of wheezing by age 3 years.
Methods:
We studied 932 children in a prospective cohort of children. The main outcome was recurrent wheezing, which was defined as parents' report of wheezing between 2 and 3 years of age plus wheezing in either year 1 or 2 of life. Secondary outcomes included any wheezing from 6 months to 3 years and current asthma. We used multiple logistic regression to examine associations of 6-month WFL z scores with these outcomes.
Results:
At 6 months, the infants' mean WFL z score was 0.68 (SD, 0.94; range -2.96 to 3.24). By age 3 years, 14% of children had recurrent wheezing. After adjustment for a variety of potential confounders, we found that each 1-unit increment in 6-month WFL z score was associated with greater odds of recurrent wheezing (odds ratio [OR], 1.46; 95% CI, 1.11-1.91) and any wheezing (OR, 1.23; 95% CI, 1.03-1.48). We observed a weaker association between 6-month WFL z score and current asthma (OR, 1.22; 95% CI, 0.94-1.59).
Conclusion:
Infants with higher WFL z scores at 6 months of age had a greater risk of recurrent wheezing by age 3 years. It is unclear whether the relationship of infant adiposity and early-life wheeze extends to allergic asthma or wheeze that can persist into later childhood. Our findings suggest that early interventions to prevent excess infant adiposity might help reduce children's risk of asthma-related symptoms.
More Related Videos
Related Concept Videos
Obesity
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction
Asthma III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

